Table 6 Association of EGFR exon 19 del with studied parameter
EGFR exon 19 del rs121913438 | Wild genotype | Mutant genotype | P | |||
|---|---|---|---|---|---|---|
(WW) | WD + DD | |||||
n | % | n | % | |||
Pathology | adenocarcinoma | 60 | 75.9% | 38 | 84.4% | 0.081 |
large cell carcinoma | 6 | 7.6% | 6 | 13.3% | ||
squamous cell | 7 | 8.9% | 1 | 2.2% | ||
Others | 6 | 7.6% | 0 | 0.0% | ||
Grade | 1 | 1 | 1.3% | 1 | 2.2% | 0.456 |
2 | 23 | 30.7% | 18 | 40.0% | ||
3 | 51 | 68.0% | 26 | 57.8% | ||
Stage | I | 2 | 2.5% | 0 | 0.0% | 0.150 |
II | 2 | 2.5% | 1 | 2.2% | ||
III | 20 | 25.3% | 5 | 11.1% | ||
IV | 55 | 69.6% | 39 | 86.7% | ||
Tumor cytochemistry | TTF1 | 34 | 43.0% | 30 | 66.7% | 0.015 |
CK7 | 53 | 67.1% | 35 | 77.8% | 0.403 | |
napsin A | 27 | 34.2% | 15 | 33.3% | 0.874 | |